Navigation Links
Neurologist Advises: Botox for Chronic Migraines Provides Relief to Those Suffering
Date:7/16/2014

(PRWEB) July 16, 2014

For adults with Chronic Migraines, clinically indicated as 15 or more headache days a month, each lasting 4 hours or more, BOTOX® is the first and only FDA-approved preventive treatment proven to reduce headache days every month. BOTOX® can prevent up to nine headache days a month. Brody Henkel, M.D. of Neurological Specialties of Tampa is now speaking about the administration of Botox within his practice to help those suffering from this chronic condition and want to shed light on this new prevention therapy.

Not knowing when a headache or migraine will occur can be challenging. While other treatments may help you once you already have a headache, a preventive medication like BOTOX® therapy is approved to help prevent headache days.

BOTOX® (onabotulinumtoxinA) is a prescription medicine that is injected to prevent headaches in adults with chronic migraines, according to Allergan, the manufacturer of BOTOX®. There are many ways to manage Chronic Migraines; most medications are either acute or preventive.

Headache Specialists often prescribe preventive medications for Chronic Migraine patients; however, a treatment plan may include acute and preventive treatment, so it's important to understand how they work to manage Chronic Migraines.

Henkel provides insight that patients should discuss with their doctor whether it is appropriate for them to include BOTOX® as a preventative treatment. Appropriate questions to consider should include:

1. On average, how many days each month do you experience headaches?
2. On average, how many days per month are you headache-free?
3. Do you have headaches that last 4 hours or more?
4. Do you experience nausea, vomiting, sensitivity to light or sound with your headaches?
5. How much of an effect do headaches and/or migraines have on your daily life?

“It may take several weeks for a patient to experience a response to the treatment,” says Henkel. “Patients typically experience an initial response by the time we check in for their four-week evaluation and then at 24 weeks, the treatment has proven to prevent chronic migraines.”

BOTOX® therapy is injected every 12 weeks.

Henkel also explains, “A total of 31 injections are made to seven key areas of the head and neck. We use very fine needles, so that the injections feel like tiny pinpricks. Some patients experience temporary mild discomfort, but overall the treatment is fairly manageable for our patients.”

About Neurological Specialties: Founded in 1980, Neurological Specialties is the only medical group in the Tampa Bay area with both neurologists and neurosurgeons together in the same practice. The office is located at 2816 West Virginia Avenue, in Tampa, Florida. For more information, visit http://www.neurologicalspecialties.com.

About Dr. Henkel:

A Florida native, Dr. Brody L. Henkel graduated from the University of Florida, earned his medical degree at St. George’s University, and completed his Neurology Residency and Fellowship in Clinical Neurophysiology at the Medical University of South Carolina in Charleston. Dr. Henkel is a Diplomate of the American Board of Psychiatry and Neurology, and is board eligible in Electrodiagnostic Medicine. He has a special interest in the delivery of EMG/NCS and EEG studies, which are available in the office on a full-time basis.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12023430.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Loyola neurologist is co-editor of 3-volume, 1,480-page guide to clinical neurology
2. Microbleeds important to consider in brain-related treatments, UCI neurologist says
3. UNC child neurologist finds potential route to better treatments for Fragile X, autism
4. Neurologist Dr. Marisa C. Chang of Neurological Associates of West Los Angeles Has Been Named a Southern California Rising Star by Super Doctors®
5. Neurologists report unique form of musical hallucinations
6. Many neurologists unaware of safety risks related to anti-epilepsy drugs
7. Alzheimers Patients May Face Looming Shortage of Neurologists
8. The doctor wont see you now? Study: US facing a neurologist shortage
9. Hospital-based neurologists worry about career burnout
10. 2 books by Loyola neurologist Highly Commended by British Medical Association
11. Decrease Fine Lines and Wrinkles with Face Whisperer® Day Cream with Argireline®, Known as the Natural Botox; On Sale Now at Sublime Beauty®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to ... rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive open ... resume and wondering if it’s as ready as you are for a new job ...
(Date:4/27/2017)... ... 27, 2017 , ... SyncDog, Inc. , the leading ... Live! 2017 in Santa Clara, California. Each year, MobileIron Live! assembles mobility ... organizations maximize the benefits of mobility in their operations securely. MobileIron ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is ... been asked to present at the upcoming Aesthetic Meeting. Held in San Diego, at ... Drs. Furnas and Canales will lend their expertise to the Premier Global Hot Topics ...
(Date:4/26/2017)... WASHINGTON, DC (PRWEB) , ... ... ... Telemedicine Association (ATA) is thrilled to announce the ATA 2017 President’s Awards ... telehealth innovation and demonstrated superior healthcare delivery. , The ATA 2017 ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... 19, 2017 Companion ... response in pets such as canine, avian and ... various types such as Attenuated Live Vaccines, Conjugate ... Vaccines and Recombinant Vaccines. Attenuated live vaccines are ... bacteria, which have been weakend under laboratory conditions. ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
Breaking Medicine Technology: